Oral preparation of dyclonine hydrochloride
US7696228B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2006 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Jun 16, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P23/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses an oral preparation of dyclonine hydrochloride for the endoscopic examination in upper gastrointestinal tract, which has the effects of anesthetization and lubrication, and an oral preparation comprising dyclonine hydrochloride that has the advantages of avoiding foam in the body cavity, preventing vomiting, and offering a clear view. The preparation of the present invention comprises, as main ingredients, 0.2%-3% weight percent of dyclonine hydrochloride, 1%-12% weight percent of polyvinyl alcohol, 1%-10% volume percent of glycerin, 1%-10% volume percent of a defoaming agent, and a balance of a pharmaceutically acceptable adjuvant. The viscosity of the preparation is in a range of 30 to 300 mpa·s and the pH value is in a range of 2.0 to 8.0.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.